Daewoong Urushatjeong, no liver improvement effect... Surrenders to the Ministry of Food and Drug Safety

Daewoong Pharmaceutical was fined for advertising a product as if it had liver function improvement effects, even though it is not a pharmaceutical product.

Daewoong even filed a lawsuit against the authorities, but ultimately surrendered.

The problematic product is a quasi-drug called 'UruShot Tablets'.

Because it has a name similar to Daewoong's flagship medication 'Ursan' and features a liver-shaped image on the packaging, consumers are easily led to believe that it has liver-improving effects like Ursan.

Therefore, the Ministry of Food and Drug Safety imposed a one-month suspension of advertising activities for UruShot tablets in 2023 and fined Daewoong 29.1 million won.

In 2021, there was also a one-month advertising ban imposed on Urushatjeong due to allegations of exaggerated advertising.

It is specified in the product description that it contains ingredients that detoxify the liver and help relieve fatigue.

As consumer interest in medical supplies and health functional foods increases, the related market is also experiencing growth.

There are also criticisms that management and supervision need to be strengthened as even large pharmaceutical companies are increasingly exaggerating the effectiveness.

===============================

Actually, gum medicines don't really help the gums much...

It seems this Urushat is the same...